ESTA Establishment Labs Holdings Inc.

NASDAQ
$79.47

Establishment Labs Holdings Inc. (ESTA) is expected to report earnings on November 5, 2026, before the market open. The consensus earnings estimate is a loss of $0.31 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -11.0% since its last earnings release on August 6, 2026.

Establishment Labs Missed Consensus Estimates, Raises Guidance
Thursday, August 6, 2026 · 8:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 8:00 AM ET
Earnings Whisper
-
vs ($0.31)
Rev est $66.03M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $76.90

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Establishment Labs Holdings Inc.

Establishment Labs Holdings Inc. is a global medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants®, the centerpiece of the MotivaImagine® platform.

Sector

Healthcare

Industry

Medical Appliances/Equipment